Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker

CompletedOBSERVATIONAL
Enrollment

2,502

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

September 30, 2011

Study Completion Date

December 31, 2011

Conditions
PregnancyAneuploidyDown SyndromeEdwards Syndrome
Trial Locations (35)

19107

Thomas Jefferson University Hospital, Philadelphia

27103

Lyndhurst Gynecologic Associates, Winston-Salem

29425

Medical University of South Carolina, Charleston

31026

Hopital Paule de Viguier - CHU Toulouse, Toulouse

33136

University of Miami, Miami

33143

South Florida Perinatal Medicine, Miami

33323

Global Ob/Gyn Centers, Pembroke Pines

Discovery Clinical Research, Sunrise

Sheridan Clinical Research, Sunrise

33472

Visions Clinical Research, Boynton Beach

37044

Centre Hospitalier Regional et Universitaire - Hopital Bretonneau, Tours

37203

Perinatal Research Center, Nashville

Tenessee Maternal Fetal Medicine, Nashville

37660

Kingsport Perinatology, Kingsport

43231

Complete Healthcare for Women, Columbus

44093

Centre Hospitalier Universitaire de Nantes, Nantes

48073

William Beaumont Hospital, Royal Oak

49503

Spectrum Health - Maternal Fetal Medicine, Grand Rapids

55905

Mayo Clinic, Rochester

60602

Reproductive Genetics Institute, Chicago

63117

St Louis University, St Louis

68022

Methodist Hospital, Omaha

75019

Hopital Cochin Port Royal, Paris

Hopital Robert Debre, Paris

77054

Houston Perinatal Associates, Houston

83712

Women's Clinic, Boise

91942

Grossmont Center for Clinical Research, La Mesa

92121

IGO, San Diego

92123

San Diego Perinatal Center, San Diego

Women's Healthcare at Frost Street, San Diego

92128

Poway Womens Care, San Diego

96814

Fetal Diagnostic Institution of the Pacific, Honolulu

97401

Clinical Trials of America, Eugene

36604-3302

University of South Alabama, Mobile

08103

Cooper University Hospital, Camden

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

PRA Health Sciences

INDUSTRY

lead

Sequenom, Inc.

INDUSTRY